News tagged with tumor suppression

Clinical trial targets advanced prostate cancer

Select patients with advanced prostate cancer may benefit from a Georgia Health Sciences University Cancer Center clinical trial that looks to improve survival rates of the FDA-approved prostate cancer drug Provenge.

Dec 03, 2012
popularity 5 / 5 (1) | comments 0